What Is the New Medicine for Bronchiectasis? A Look at Brinsupri (brensocatib)
•
3 min read
In a major advancement for respiratory medicine, the U.S. Food and Drug Administration (FDA) officially approved the first-ever treatment specifically for bronchiectasis in August 2025. This groundbreaking new medicine for bronchiectasis is called Brinsupri (brensocatib), an oral medication that represents a significant shift from previous symptom-focused management strategies by directly addressing a root cause of inflammation.
